Evidence map›Paper›PMID 24167743›Full record

ReviewISRN oncology2013

From radical mastectomy to breast-conserving therapy and oncoplastic breast surgery: a narrative review comparing oncological result, cosmetic outcome, quality of life, and health economy.

Ahmad Kaviani, Nassim Sodagari, Sara Sheikhbahaei, Vahid Eslami, Nima Hafezi-Nejad, Amin Safavi, Maryam Noparast, Alfred Fitoussi

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in ISRN oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05724758 (Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05724758 unknown statusnot on this mapstarted 2023, after this paper: background citation

Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery

TypeobservationalSponsorBrust-Zentrum AGRan2023 to 2024Enrolled100ConditionsBreast Cancer Stage I, Breast Cancer Stage II, Breast Cancer in SituArmsBreast-conserving surgery
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ahmad KavianiDepartment of General Surgery, Tehran University of Medical Sciences (TUMS), P.O. Box 13145-158, Tehran, Iran ; Kaviani Breast Disease Institute (KBDI), P.O. Box 14358-6443, Tehran, Iran.
Nassim Sodagari
Sara Sheikhbahaei
Vahid Eslami
Nima Hafezi-Nejad
Amin Safavi
Maryam Noparast
Alfred Fitoussi
Tehran University of Medical Sciences · IRMotamed Cancer Institute · IRInstitut Curie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical management of breast cancer has evolved considerably over the last two decades. There has been a major shift toward less-invasive local treatments, from radical mastectomy to breast-conserving therapy (BCT) and oncoplastic breast surgery (OBS). In order to investigate the efficacy of each of the three abovementioned methods, a literature review was conducted for measurable outcomes including local recurrence, survival, cosmetic outcome, quality of life (QOL), and health economy. From the point of view of oncological result, there is no difference between mastectomy and BCT in local recurrence rate and survival. Long-term results for OBS are not available. The items assessed in the QOL sound a better score for OBS in comparison with mastectomy or BCT. OBS is also associated with a better cosmetic outcome. Although having low income seems to be associated with lower BCT and OBS utilization, prognosis of breast cancer is worse in these women as well. Thus, health economy is the matter that should be studied seriously. OBS is an innovative, progressive, and complicated subspeciality that lacks published randomized clinical trials comparing surgical techniques and objective measures of outcome, especially from oncologic and health economy points of view.

Identifiers

PMID24167743
PMCPMC3791839
OpenAlexW1983177674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.